Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
BörsenkürzelTKNO
Name des UnternehmensAlpha Teknova Inc
IPO-datumJun 25, 2021
CEOMr. Stephen Gunstream
Anzahl der mitarbeiter173
WertpapierartOrdinary Share
GeschäftsjahresendeJun 25
Addresse2451 Bert Drive
StadtHOLLISTER
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl95023
Telefon18316371100
Websitehttps://www.teknova.com/
BörsenkürzelTKNO
IPO-datumJun 25, 2021
CEOMr. Stephen Gunstream
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten